First quarter 2022 results
AstraZeneca PLC29 April 2022 07:00 GMT First quarter 2022 results Strong start to the year. Continued investment in the pipeline to drive sustainable long-term growth. Revenue and EPS summary [][][][][][] Q1 2022 % Change $m Actual CER[1]- Product Sales 10,980 51 56 - Collaboration Revenue 410 n/m [2] n/m Total Revenue 11,390 56 60 Reported[3] EPS[4] $0.25 (79) (73)Core[5] EPS [6]